Priapism: Difference between revisions

No edit summary
Line 16: Line 16:


;Causes:
;Causes:
#[[Sickle Cell Disease]]<ref>Miller ST, Rao SP, Dunn EK, Glassberg KI. Priapism in children with sickle cell disease. J Urol. Aug 1995;154(2 Pt 2):844-7</ref>
*[[Sickle Cell Disease]]<ref>Miller ST, Rao SP, Dunn EK, Glassberg KI. Priapism in children with sickle cell disease. J Urol. Aug 1995;154(2 Pt 2):844-7</ref>
#Medication induced
*Medication induced
#Leukemia
*Leukemia
#Infection
*Infection
#High rate of impotence afterwards if present for > 24hrs
*High rate of impotence afterwards if present for > 24hrs
#[[Cocaine]] use<ref>reen J, Hakim L. Cocaine-induced veno-occlusive priapism: importance of
*[[Cocaine]] use<ref>reen J, Hakim L. Cocaine-induced veno-occlusive priapism: importance of
urine toxicology screening in the emergency room setting. Clin Urol. 1999;161</ref>
urine toxicology screening in the emergency room setting. Clin Urol. 1999;161</ref>


Line 32: Line 32:


== Work-Up ==
== Work-Up ==
#CBC&nbsp;&nbsp; (eval leukemia, sickle cell)
*CBC&nbsp;&nbsp; (eval leukemia, sickle cell)
#Type and screen (may need to exchange transfusion)
*Type and screen (may need to exchange transfusion)
#Coags  
*Coags  
#Urinalysis/tox (etoh, marijuana, cocaine can cause priapism)
*Urinalysis/tox (etoh, marijuana, cocaine can cause priapism)
#ABG from cavernosa (if hx unclear): Hypoxic, hypercapneic, acidotic → low flow
*ABG from cavernosa (if hx unclear): Hypoxic, hypercapneic, acidotic → low flow
#Ultrasound  
*Ultrasound  
##Can distinguish between high-flow and low-flow
**Can distinguish between high-flow and low-flow


== Differential Diagnosis ==
== Differential Diagnosis ==
Line 48: Line 48:


== Treatment ==
== Treatment ==
#Written consent prior to invasive procedure
*Written consent prior to invasive procedure
##Regardless of treatment there is a high risk of impotence  
**Regardless of treatment there is a high risk of impotence  
#Pain control
*Pain control
##Morphine and/or penile block  
**Morphine and/or penile block  
===Penile Block===
===Penile Block===
*Often required prior to injections
*Often required prior to injections
Line 58: Line 58:
===Low Flow Priapism===
===Low Flow Priapism===
====Sickle Cell Disease====
====Sickle Cell Disease====
#IV hydration  
*IV hydration  
#O2  
*O2  
#Transfusion for goal HCT>30% with consultation for partial exchange transfusion (HGB-S<30%)
*Transfusion for goal HCT>30% with consultation for partial exchange transfusion (HGB-S<30%)
##Exchange transfusion is associated with '''ASPEN syndrome'''('''A'''ssociation of '''S'''ickle cell '''P'''riapism, '''E'''xchange transfusion & '''N'''eurological events)
**Exchange transfusion is associated with '''ASPEN syndrome'''('''A'''ssociation of '''S'''ickle cell '''P'''riapism, '''E'''xchange transfusion & '''N'''eurological events)




#Urology consult (especially important with traumatic priapism)
*Urology consult (especially important with traumatic priapism)


====Aspiration of corpus cavernosum ====
====Aspiration of corpus cavernosum ====
Line 74: Line 74:


====α/β-2 Agonist====
====α/β-2 Agonist====
#'''Terbutaline'''<ref>Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. Jul 1993;42(1):51-3</ref>
*'''Terbutaline'''<ref>Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. Jul 1993;42(1):51-3</ref>
##Dose: 0.25-0.5mg SQ in deltoids OR 5-10mg PO, may repeat in q20min  
**Dose: 0.25-0.5mg SQ in deltoids OR 5-10mg PO, may repeat in q20min  
#'''Phenylephrine'''
*'''Phenylephrine'''
##Dilute phenylephrine 1mg in 9mL NS for final concentration of 100mcg/mL  
**Dilute phenylephrine 1mg in 9mL NS for final concentration of 100mcg/mL  
##Inject base of penis with 29-Ga needle (after blood aspiration to confirm position) 0.5-1mL q3-5min until resolution or one hour (max 1500mcg)
**Inject base of penis with 29-Ga needle (after blood aspiration to confirm position) 0.5-1mL q3-5min until resolution or one hour (max 1500mcg)
##Only one side needs to be injected since there exists a vascular channel between the 2 corpora cavernos
**Only one side needs to be injected since there exists a vascular channel between the 2 corpora cavernos
##Compress injection area to prevent hematoma formation
**Compress injection area to prevent hematoma formation
##Use with caution in cardiovascular disease
**Use with caution in cardiovascular disease


;Wrap penis in elastic bandage after detumescence is achieved
;Wrap penis in elastic bandage after detumescence is achieved
Line 90: Line 90:
== Disposition ==
== Disposition ==


#Admit if refractory to treatment or need or IR or surgical intervention
*Admit if refractory to treatment or need or IR or surgical intervention
#May dispo home if treatment is successful with close follow-up by urology
*May dispo home if treatment is successful with close follow-up by urology


== Source ==
== References ==
<references/>
<references/>


[[Category:GU]]  
[[Category:GU]]  
[[Category:Procedures]]
[[Category:Procedures]]

Revision as of 20:30, 25 September 2015

Background

  • Prolonged, unwanted erection not a/w sexual stimulation > 4h
  • May lead to erectile dysfunction and penile necrosis if untreated

Types

High-flow (nonischemic)

  • Extremely rare and usually not painful
  • AV fistula from trauma (lacerated cavernous artery shunts blood into cavernous bodies)
  • Ischemia/impotence does not occur
  • Requires less urgent intervention and does not lead to impotence

Low-flow (ischemic)

  • Most common type
  • Veno-occlusion causing pooling of deoxygenated blood in cavernous tissue
  • A urologic emergency
Causes
ABG Analysis
  • Low-flow priapism is suggested by aspirated blood with a pH of < 7.25, pO2 < 30 mmHg, and pCO2 > 60 mmHg

Clinical Features

  • Erect corpus cavernosum
  • Flacid glans and spongiosum

Work-Up

  • CBC   (eval leukemia, sickle cell)
  • Type and screen (may need to exchange transfusion)
  • Coags
  • Urinalysis/tox (etoh, marijuana, cocaine can cause priapism)
  • ABG from cavernosa (if hx unclear): Hypoxic, hypercapneic, acidotic → low flow
  • Ultrasound
    • Can distinguish between high-flow and low-flow

Differential Diagnosis

Treatment

  • Written consent prior to invasive procedure
    • Regardless of treatment there is a high risk of impotence
  • Pain control
    • Morphine and/or penile block

Penile Block

  • Often required prior to injections
  • Use 27G needle for penile nerve block at 2 and 10 o'clock position at base of penis (or penile ring block)

Low Flow Priapism

Sickle Cell Disease

  • IV hydration
  • O2
  • Transfusion for goal HCT>30% with consultation for partial exchange transfusion (HGB-S<30%)
    • Exchange transfusion is associated with ASPEN syndrome(Association of Sickle cell Priapism, Exchange transfusion & Neurological events)


  • Urology consult (especially important with traumatic priapism)

Aspiration of corpus cavernosum

  • Rarely beneficial after 48hr
  • Local anesthesia at puncture
  • Aspirate blood from corpus cavernosum (3 or 9 o'clock position of shaft) w/ 16-19ga needle
  • Blood sludging makes aspiration difficult, so to improve flow dynamics use saline irrigation and repeated aspirations
  • After removal of 20-30cc of blood, you may inject and aspirate 10-20cc aliquots

α/β-2 Agonist

  • Terbutaline[4]
    • Dose: 0.25-0.5mg SQ in deltoids OR 5-10mg PO, may repeat in q20min
  • Phenylephrine
    • Dilute phenylephrine 1mg in 9mL NS for final concentration of 100mcg/mL
    • Inject base of penis with 29-Ga needle (after blood aspiration to confirm position) 0.5-1mL q3-5min until resolution or one hour (max 1500mcg)
    • Only one side needs to be injected since there exists a vascular channel between the 2 corpora cavernos
    • Compress injection area to prevent hematoma formation
    • Use with caution in cardiovascular disease
Wrap penis in elastic bandage after detumescence is achieved

High Flow Priapism

  • Requires urologic consultation for surgical correction or IR guided emobolization[5]

Disposition

  • Admit if refractory to treatment or need or IR or surgical intervention
  • May dispo home if treatment is successful with close follow-up by urology

References

  1. Miller ST, Rao SP, Dunn EK, Glassberg KI. Priapism in children with sickle cell disease. J Urol. Aug 1995;154(2 Pt 2):844-7
  2. reen J, Hakim L. Cocaine-induced veno-occlusive priapism: importance of urine toxicology screening in the emergency room setting. Clin Urol. 1999;161
  3. Quan D, Ruha AM. Priapism associated with Latrodectus mactans envenomation. Am J Emerg Med. Jul 2009;27(6):759.e1-2
  4. Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. Jul 1993;42(1):51-3
  5. Sandro C. High-flow priapism: treatment and long-term follow-up. 2002. 59(1).110–113 PDF